Skip to main content
. 2000 Jul 22;321(7255):199–204. doi: 10.1136/bmj.321.7255.199

Table 2.

Odds of coronary heart disease in men who had values of inflammatory factors in top third of distribution of controls relative to those who had values in bottom third of this distribution

Factor (tertile cut offs) No of cases
No of controls
Odds ratio (95% CI) adjusted for:
Top Middle Bottom Top Middle Bottom Age and town Age, town, and smoking Age, town, smoking, and risk factors* Age, town, smoking, risk factors, socioeconomic status
All 506 cases and 1025 controls
 C reactive protein (2.4 and 0.9 mg/l) 268 150 88 347 298 380 3.46 (2.59 to 4.62) 3.32 (2.47 to 4.47) 2.92 (2.13 to 4.01) 2.13 (1.38 to 3.28)
Serum amyloid A protein (9 and 6 mg/l) 255 144 107 362 351 312 2.12 (1.60 to 2.80) 2.13 (1.61 to 2.82) 1.66 (1.22 to 2.26) 1.65 (1.07 to 2.55)
Leucocyte count (7.8 and 6.4×109/l) 212 168 110 332 329 330 1.89 (1.43 to 2.51) 1.69 (1.25 to 2.28) 1.46 (1.06 to 2.00) 1.12 (0.71 to 1.77)
Albumin (46 and 44 g/l) 174 141 191 348 347 327 0.83 (0.63 to 1.10) 0.90 (0.68 to 1.20) 0.61 (0.44 to 0.83) 0.67 (0.43 to 1.04)
329 cases and 820 controls without evidence of coronary heart disease at entry
 C reactive protein (2.4 and 0.9 mg/l) 164 95 70 265 234 321 2.93 (2.10 to 4.09) 2.74 (1.95 to 3.85) 2.61 (1.81 to 3.77) 2.31 (1.42 to 3.76)
Serum amyloid A protein (9 and 6 mg/l) 163 87 79 284 288 248 1.90 (1.37 to 2.64) 1.93 (1.38 to 2.68) 1.50 (1.05 to 2.16) 1.67 (1.02 to 2.74)
Leucocyte count (7.8 and 6.4×109/l) 142 104 71 253 261 277 2.19 (1.56 to 3.07) 1.87 (1.30 to 2.68) 1.57 (1.07 to 2.30) 1.34 (0.80 to 2.27)
Albumin (46 and 44 g/l) 115 95 118 282 266 269 0.90 (0.64 to 1.26)  1.0 (0.71 to 1.41) 0.65 (0.45 to 0.95) 0.75 (0.45 to 1.25)
*

Blood pressure, total cholesterol, high density lipoprotein cholesterol, triglycerides, body mass index 

Occupation, housing tenure, marital status, car ownership, and childhood socioeconomic factors (father's occupation, family car ownership, bathroom in house, hot water tap in house, bedroom sharing, height). 

Analyses of acute phase reactants and coronary heart disease were not adjusted for values of other inflammatory markers to avoid possible overadjustment (see results).